In the EDITION 2 trial published in Diabetes Care, researchers compared safety and efficacy of the new insulin glargine 300 U/L dose with the insulin glargine 100 U/L dose in patients with type 2 diabetes on insulin and taking oral diabetes medications.

Findings offer insight into the similarities between these treatments, thereby adding to the evidence base of whether the new dose will be an effective treatment.

READ FULL ARTICLE Curated publisher From Diabetesjournals